CAPEOX trials for Colorectal cancer

All CAPEOX trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying CAPEOX for Colorectal cancer

• A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
  NCT06567782 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 33 locations
• HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
  NCT06709885 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer
  NCT05576480 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
  NCT05855200 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 266 locations

Common questions

How many trials study CAPEOX for Colorectal cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.